Healthcare
111, Inc.(YI)
Live Price
Offline$4.41
+0.00% today
1Y Change
-40.49%
Window
Jun 23, 2025 โ Jun 15, 2026
- Market Cap
- $350.00M
- Revenue Growth
- -15.2%
- EPS Growth
- +1.3%
- Dividend Yield
- 0.0%
Coverage: 247 bars ยท Jun 23, 2025 โ Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
111, Inc. (YI) is a Healthcare stock with a market cap of $350.00M and listed on NASDAQ. The stock last traded around $4.41 and down 40.5% across the available one-year price window (Jun 23, 2025 โ Jun 15, 2026). Baseline metrics include revenue growth of -15.2%, EPS growth of +1.3%, a dividend yield of 0.0%. What stands out right now is revenue -15.2%, EPS +1.3%, free cash flow -53.7% with operating margin -0.1% and ROIC -1.5%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines YI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-15.2% vs +7.6% peer median
Operating Margin
Below sector median
-0.1% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 21, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -15.2% and EPS is at +1.3%, with operating margin around -0.1%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -6.5% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 21, 2026 | โ | +3.6% | -4.0% | โ |
2026 Mar 30, 2026 | โ | +1.4% | -3.3% | +1.9% |
2025 Dec 17, 2025 | โ | +4.3% | -12.2% | +60.5% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
YI
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
YI Max Drawdown
-67.10%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for YI and SPY.
Company Overview
111, Inc.
NASDAQ Global Market
111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers. It offers prescription and over-the counter drugs, including western and traditional Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices comprising bandages and thermometers; and personal care products consisting of skin care, birth control, and sexual wellness products; and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Pharmacy, which include pharmacies and wholesalers; and data and supply chain integration services. As of December 31, 2021, it operated 14 offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Tianjin, Kunshan, Chongqing, and Wuhan provinces. In addition, the company offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies and distributors, medical professionals, and insurance companies. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.
- Leadership
- Junling Liu
- IPO Date
- Sep 12, 2018
- Employees
- 1.2k
- Street Address
- No.295 ZuChongZhi Road
- Mailing
- Shanghai, 201203
- Region
- Shanghai, CN
- Reporting Currency
- USD
- Investor Line
- 86 21 2053 6666
- Last Updated
- May 6, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- 1.8
- Price/Sales
- 0.0
- Price/Book
- โ
Growth
- Revenue
- -15.2%
- EPS
- +1.3%
- Free Cash Flow
- -53.7%
Profitability
- Gross Margin
- 5.8%
- Operating Margin
- -0.1%
- Net Margin
- -0.4%
- ROE
- 8.3%
- ROIC
- -1.5%
Balance Sheet
- Debt/Equity
- โ
- Current Ratio
- 1.09
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.